Ticker
APRECompany Name
APREA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 17.31M | $ 841.01K | 4.86% |
3/31/2025 | $ 20.22M | $ 1.28M | 6.35% |
12/31/2024 | $ 23.98M | $ 1.5M | 6.27% |
9/30/2024 | $ 26.89M | $ 1.31M | 4.87% |
6/30/2024 | $ 29.96M | $ 1.28M | 4.26% |
3/31/2024 | $ 33.2M | $ 963.8K | 2.9% |
12/31/2023 | $ 22.65M | $ 583.23K | 2.57% |
9/30/2023 | $ 25.77M | $ 569.16K | 2.21% |
6/30/2023 | $ 28.68M | $ 249.69K | 0.87% |
3/31/2023 | $ 32.02M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for APREA THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 102.83M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 84.08% |
average | 20.16% |
median | 15.34% |
std | 19.94% |